Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Prevalence of metabolic syndrome among patients with Alzheimer disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Alzheimer’s disease: exploring the landscape of cognitive decline.
10.1021/acschemneuro.4c00339 · 2024 · External reference
GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.
10.1016/s2468-2667(21)00249-8 · 2022 · External reference
Metabolic syndrome and dementia: independent risk factors or a unified pathway?
10.1177/13872877251359635 · 2025 · External reference
Associations between metabolic syndrome and type of dementia: analysis based on the National Health Insurance Service database of Gangwon province in South Korea.
10.1186/s13098-020-00620-5 · 2021 · External reference
Alzheimer’s disease as type 3 diabetes: understanding the link and implications.
10.3390/ijms252211955 · 2024 · External reference
Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.
10.1007/s10522-017-9701-0 · 2017 · External reference
Association of metabolic syndrome with Alzheimer disease: a population-based study.
10.1212/01.wnl.0000234037.91185.99 · 2006 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
10.1016/j.ijsu.2021.105906 · 2021 · External reference
Prevalence of Alzheimer’s dementia and its risk factors in community-dwelling elderly Koreans.
10.4306/pi.2008.5.2.78 · 2008 · External reference
An evaluation of metabolic syndrome and its components in Alzheimer’s disease: does gender make a difference?
2011 · External reference
The metabolic syndrome, diabetes, and Alzheimer’s disease.
2010 · External reference
Cognitive and affective functions in Alzheimer’s disease patients with metabolic syndrome.
10.1111/ene.12845 · 2016 · External reference
The metabolic syndrome and Alzheimer disease.
10.1001/archneur.64.1.93 · 2007 · External reference
Regulated upon activation, normal T cell expressed and secreted (RANTES) levels in the peripheral blood of patients with Alzheimer’s disease.
10.4103/1673-5374.295340 · 2021 · External reference
Metabolic syndrome and cerebrovascular impairment in Alzheimer’s disease.
10.1002/gps.4269 · 2015 · External reference
ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis.
10.1136/bmj-2023-076754 · 2023 · External reference
The brain as an insulin-sensitive metabolic organ.
10.1016/j.molmet.2021.101234 · 2021 · External reference
Insulin signaling in the central nervous system: learning to survive.
10.1016/j.pneurobio.2006.06.003 · 2006 · External reference
Insulin resistance and neurodegeneration: progress towards the development of new therapeutics for Alzheimer’s disease.
10.1007/s40265-016-0674-0 · 2017 · External reference
Insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer’s disease.
10.1016/j.neuint.2020.104707 · 2020 · External reference
Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease.
10.3389/fnagi.2021.617588 · 2021 · External reference
Metabolic dysfunction and mitochondrial failure in Alzheimer’s disease: integrating pathophysiology, clinical evidence and emerging interventions.
10.3389/fneur.2026.1772036 · 2026 · External reference
